Trending Articles

article thumbnail

Novartis signs agreement to acquire Anthos for $925m upfront

Pharmaceutical Technology

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.

256
256
article thumbnail

AbbVie, Pfizer gain FDA OK for novel antibiotic

Bio Pharma Dive

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.

Bacteria 248
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Radical Study Proposes a Single Cause to Explain Alzheimer’s Disease

AuroBlog - Aurous Healthcare Clinical Trials blog

(koto_feja/E+/Getty Images) A new model of Alzheimer’s disease has been proposed, which could speed up efforts to understand and cure the complex condition while bringing all manifestations of the condition under one unifying theory.

RNA 193
article thumbnail

February 12, 2025: Results of ACP PEACE, an NIH Collaboratory Trial, in This Week’s PCT Grand Rounds

Rethinking Clinical Trials

In this Friday’s PCT Grand Rounds, Angelo Volandes of Dartmouth Health and James Tulsky of Dana-Farber Cancer Institute will present “A Cluster Randomized, Stepped-Wedge Pragmatic Trial to Enhance Goals-of-Care Communication for Older Adults With Cancer (ACP-PEACE).” The Grand Rounds session will be held on Friday, February 14, 2025, at 1:00 pm eastern.

Trials 148
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Scientists peel away the mystery of JAK enzymes, which play roles in everything from eczema to ulcerative colitis

Medical Xpress

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the average TV watcher knows exactly what JAK stands for.

Scientist 135
article thumbnail

Obesity market to reach $173.5 billion by 2031

Pharmaceutical Technology

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.

Marketing 254

More Trending

article thumbnail

Can a Supplement Really Help You Control Your Pesky Eye Floaters?

AuroBlog - Aurous Healthcare Clinical Trials blog

(Filipp Romanovski/Unsplash) If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision.

article thumbnail

Hemgenix shows efficacy among haemophilia B patients

Pharma Times

CSL Behring's study reveals significant long-term benefits

133
133
article thumbnail

Mitochondria's role in diabetes: Could reversing damage offer a cure?

Medical Xpress

Mitochondria are essential for generating energy that fuels cells and helps them function.

Research 131
article thumbnail

FDA approves Gomekli as first neurofibromatosis drug for adults

Pharmaceutical Technology

Merck acquisition target SpringWorks will go toe-to-toe with AstraZeneca in the US neurofibromatosis market.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

A brain biotech launches with Roche’s spare parts

Bio Pharma Dive

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

article thumbnail

There’s Never Been a More Dangerous Time to Use Street Drugs. Here’s Why

AuroBlog - Aurous Healthcare Clinical Trials blog

In the early hours of September 14 2021, three men parked in a quiet car park in the southern English market town of Abingdon-on-Thames. The men, returning from a night out, had pulled over to smoke heroin.

Drugs 146
article thumbnail

Capgemini unveils AI breakthrough to boost bioeconomy

Pharma Times

New methodology may boost innovation in protein engineering

Engineer 128
article thumbnail

Human breast milk found to enhance corneal healing in new research

Medical Xpress

Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal burn but instead used her own breast milk.

Research 111
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Fourth person receives eGenesis’ gene-edited pig kidney transplant

Pharmaceutical Technology

Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.

article thumbnail

Axsome secures top drug’s future with Teva patent settlement

Bio Pharma Dive

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.

Marketing 180
article thumbnail

India needs to develop strategies to mitigate the impact of USAID funding freeze

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian pharmaceutical industry plays a crucial role in the global drug supply chain, particularly in the US. Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies.

article thumbnail

Illuccix therapy gets approval in the UK

Pharma Times

Imaging agent to improve prostate cancer detection

127
127
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Brain cells mimic muscle signaling to enhance learning and memory

Medical Xpress

New research details the subcellular structures in neurons that enable signals to be transmitted from where they are received at specific sites on dendrites to the decision-making cell body located hundreds of micrometers away. The new research finds that the endoplasmic reticulum and the plasma membrane form contact sites where specialized molecules control the release of calcium, which regulates the signals sent along the dendrite to the soma.

article thumbnail

Super Bowl ad for copycat weight loss drugs stokes pharma power debate

Pharmaceutical Technology

Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.

Drugs 205
article thumbnail

Novartis pays $925M to reel in a startup it helped launch

Bio Pharma Dive

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.

Licensing 173
article thumbnail

New Strain of Bird Flu in Nevada Reveals a Concerning Mutation

AuroBlog - Aurous Healthcare Clinical Trials blog

(Dusty Pixel photography/Getty Images) An emerging strain of highly pathogenic avian influenza has spilled over from wild birds to dairy cows in the state of Nevada, and officials at the US Department of Agriculture (USDA) and some scientists are concerned by a mutation they are seeing. The viral variant, called genotype D1.

Genotype 130
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Bimekizumab shows long-term efficacy in hidradenitis suppurativa

Pharma Times

UCB's BIMZELX reveals promising two-year data at EHSF 2025

102
102
article thumbnail

Kennedy confirmed as HHS Secretary

pharmaphorum

The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.

101
101
article thumbnail

WHO and St Jude start distributing paediatric cancer medicines amid US aid cuts

Pharmaceutical Technology

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.

Medicine 200
article thumbnail

‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public

Bio Pharma Dive

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for biotech stocks.

Marketing 164
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

article thumbnail

Budget allocation to DHR witness 40% increase in FY26

AuroBlog - Aurous Healthcare Clinical Trials blog

The proposed budget allocation for the Central sector schemes of Department of Health Research (DHR), under the ministry of health and family welfare, is expected see an increase of almost 40 per cent during the fiscal year 2025-26, as compared to the initial projects under the Budget Estimates (BE) for the fiscal year 2024-25.

Research 112
article thumbnail

Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Type 2 Diabetes

JAMA Internal Medicine

This comparative effectiveness research study examines the outcomes of treatment with sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, or dipeptidyl peptidase-4 inhibitors for patients with type 2 diabetes and chronic obstructive pulmonary disease.

article thumbnail

FDA clears new antibiotic for superbug infections

pharmaphorum

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

article thumbnail

EU reshapes HTAs: is the industry ready for it?

Pharmaceutical Technology

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time